Edward Kim
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Transplantation top 2%
Papers in
- Oncology 71
- Pancreatic and Hepatic Oncology Research 25
- Colorectal Cancer Treatments and Studies 21
- Cancer Immunotherapy and Biomarkers 8
-
- Cancer Genomics and Diagnostics 12
- Co-authors
- Stephen G. YoungDiane M. SimeoneMark M. ZalupskiPatrick J. CaseyJames OttoKent A. GriffithEthan V. AbelVaibhav Sahai
- Journals
- Journal of Clinical Oncology (20 papers)Clinical Cancer Research (4 papers)Journal of Thoracic Oncology (4 papers)Clinical Colorectal Cancer (4 papers)Cancer Research (4 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Edward Kim
127 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.6k
- Transplantation 148
- Otorhinolaryngology 236
- Cancer Research 520
- Surgery 931
Countries citing papers authored by Edward Kim
This map shows the geographic impact of Edward Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Kim more than expected).
Fields of papers citing papers by Edward Kim
This network shows the impact of papers produced by Edward Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Kim. The network helps show where Edward Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial Hit paper breakdown → | 2024 | 49 |
| 3 | 2023 | 9 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 20 | |
| 8 | 2019 | 10 | |
| 9 | 2018 | 81 | |
| 10 | 2018 | 43 | |
| 11 | 2017 | 10 | |
| 12 | 2017 | 2 | |
| 13 | 2014 | 236 | |
| 14 | 2014 | 17 | |
| 15 | 2013 | 19 | |
| 16 | 2012 | 58 | |
| 17 | 2011 | 52 | |
| 18 | 2011 | 151 | |
| 19 | 2008 | 57 | |
| 20 | 2006 | 15 |
About Edward Kim
Edward Kim is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Hepatology, having authored 132 papers that have together received 3.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Colorectal Cancer Treatments and Studies (21 papers), Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (12 papers), Gastric Cancer Management and Outcomes (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Microtubule and mitosis dynamics (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (1.6k citations), Transplantation (148 citations), Otorhinolaryngology (236 citations), Cancer Research (520 citations) and Surgery (931 citations). Edward Kim has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Stephen G. Young, Diane M. Simeone, Mark M. Zalupski, Patrick J. Casey, James Otto, Kent A. Griffith, Ethan V. Abel, Vaibhav Sahai, Julio García‐Aguilar and Joel K. Greenson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Thoracic Oncology, Clinical Colorectal Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.